Publicaciones en las que colabora con José Elías García Sánchez (73)

2007

  1. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229

2006

  1. Antimicrobianos en medicina

    Prous Science

  2. Linezolid-resistant Enterococcus faecalis: First report in Spain

    Journal of Chemotherapy, Vol. 18, Núm. 4, pp. 440-442

2003

  1. Diagnóstico y tratamiento antimicrobiano de las sinusitis

    Revista Espanola de Quimioterapia

  2. Diagnóstico y tratamiento antimicrobiano de las sinusitis

    Acta Otorrinolaringologica Espanola

  3. Pseudomonas aeruginosa: Estudio multicéntrico en 136 hospitales Españoles

    Revista Espanola de Quimioterapia, Vol. 16, Núm. 1, pp. 41-52

1999

  1. In vitro activities of five new antimicrobial agents against Brucella melitensis

    International Journal of Antimicrobial Agents

  2. In vitro activities of six new fluoroquinolones against Brucella melitensis

    Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 1, pp. 194-195

1997

  1. Aztreonam/Clavulanic acid in the treatment of serious infections caused by Stenotrophomonas maltophilia in neutropenic patients: Case reports

    Journal of Chemotherapy, Vol. 9, Núm. 3, pp. 238-240

  2. Comparative evaluation of selective and nonselective media for primary isolation of Helicobacter pylori from gastric biopsies

    Helicobacter, Vol. 2, Núm. 1, pp. 36-39

  3. ESTADO ACTUAL Y PERSPECTIVAS EN EL TRATAMIENTO ANTIBIOTICO DE LAS INFECCIONES ODONTOGENAS

    Revista Espanola de Quimioterapia, Vol. 10, Núm. 3, pp. 203-211

1996

  1. Cefotaxime: current status and future prospectives after 15 years of experience

    Revista clínica española, Vol. 196 Suppl 2, pp. 67-73

  2. In vitro activity of meropenem against ciprofloxacin-resistant Enterobacteriaceae and Pseudomonas aeruginosa

    Journal of Chemotherapy, Vol. 8, Núm. 5, pp. 358-364

1995

  1. Antimicrobial resistance in Anaerobic bacteria: Current situation

    Anaerobe, Vol. 1, Núm. 2, pp. 69-80

  2. In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria

    Journal of Chemotherapy, Vol. 7, Núm. 3, pp. 189-196

  3. Multicenter Spanish study of ciprofloxacin susceptibility in gram-negative bacteria

    European Journal of Clinical Microbiology & Infectious Diseases, Vol. 14, Núm. 5, pp. 456-459

  4. Oral cephalosporins: current perspectives

    International Journal of Antimicrobial Agents, Vol. 5, Núm. 4, pp. 231-243

  5. Role of enterococci in intra-abdominal infection and possible implications in the therapeutic choice

    Revista clínica española, Vol. 195 Suppl 4, pp. 28-34

1994

  1. Activity of BAY y 3118, a novel 4-quinolone, against Brucella melitensis

    Journal of Chemotherapy, Vol. 6, Núm. 2, pp. 102-106

  2. In vitro activity of fosfomycin trometamol against urinary tract pathogens

    Revista Espanola de Quimioterapia, Vol. 7, Núm. 2, pp. 123-130